seqirus.comSeqirus | A World Leader in Influenza Vaccines

seqirus.com Profile

seqirus.com

Sub Domains:flu.seqirus.com careers.seqirus.com 

Title:Seqirus | A World Leader in Influenza Vaccines

Description:Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.

Discover seqirus.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

seqirus.com Information

Website / Domain: seqirus.com
HomePage size:67.16 KB
Page Load Time:0.195093 Seconds
Website IP Address: 12.3.33.229
Isp Server: Aventis Behring

seqirus.com Ip Information

Ip Country: United States
City Name: King of Prussia
Latitude: 40.115940093994
Longitude: -75.373741149902

seqirus.com Keywords accounting

Keyword Count

seqirus.com Httpheader

Cache-Control: private
Content-Type: text/html; charset=utf-8
Content-Encoding: gzip
Vary: Accept-Encoding
Server: Microsoft-IIS/8.5
Set-Cookie: ASP.NET_SessionId=nl1dkftmnjt0tw2rmqpl2ihe; path=/; HttpOnly; SameSite=Lax, SC_ANALYTICS_GLOBAL_COOKIE=90fdb3b3c70c4d919f00eb4b0a57e2c2|False; expires=Sun, 01-Sep-2030 09:09:13 GMT; path=/; HttpOnly, CookiePrivacyBanner=; expires=Fri, 03-Sep-2021 09:09:14 GMT; path=/, NSC_mcwt_xxx.tfrjsvt.dpn=ffffffffaf1c1ffd45525d5f4f58455e445a4a423660;Version=1;path=/;secure;httponly
CSL-Asset: W005
X-Frame-Options: SAMEORIGIN
Date: Thu, 03 Sep 2020 09:09:14 GMT
Content-Length: 16355
Strict-Transport-Security: max-age=157680000

seqirus.com Meta Info

charset="utf-8"/
content="" name="author"/
content="width=device-width, initial-scale=1.0 user-scalable=yes" name="viewport"/
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/
content="" name="keywords"/
content="Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats." name="description"/
content="default" name="csl:audience"/
content="" property="og:site_name"/
content="Seqirus" property="og:title"/
content="" property="og:type"/
content="en-US" property="og:locale"/
content="https://www.seqirus.com/" property="og:url"/
content="" property="og:image"/
content="Derived from the expression 'securing health for all of us', Seqirus has public health protection at its core. " property="og:description"/
content="summary_large_image" name="twitter:card"
content="@CSL" name="twitter:site"
content="Seqirus" name="twitter:title"
content="Derived from the expression 'securing health for all of us', Seqirus has public health protection at its core. " name="twitter:description"
content="" name="twitter:image"
content="telephone=no" name="format-detection"/
content="637347209539915516" name="VIcurrentDateTime"

12.3.33.229 Domains

Domain WebSite Title

seqirus.com Similar Website

Domain WebSite Title
seqirus.comSeqirus | A World Leader in Influenza Vaccines
sanjuanpools.comFiberglass Pool Manufacturers – Industry Leader San Juan Pools – The World’s Leader in Fiberglass Sw
helpcenter.ef.comThe World Leader in International Education EF
it.toluna.comInfluenza il Tuo Mondo | Toluna
dc.vladtv.comVladTV // World's Leader in Urban News
prairie.ducks.orgWorld Leader in Wetlands & Waterfowl Conservation
vladtv.comVladTV // World's Leader in Urban News
ftp.ueigroup.comUniversal Engraving Inc - World Leader in - UEI™ Group
sevenstar.orgSevenstar | World Leader in Online Christian Education
firstinsight.comFirst Insight - The World Leader in Next-Gen Experience Management
mygadgetguardian.lookout.comLookout | The Leader in Mobile Security for the Cloud-First World
amgfunds.comAMG Funds | World Leader in Boutique Investing
en.silvateam.comSilvateam | World leader in plant based extracts
lookout.comLookout | The Leader in Mobile Security for the Cloud-First World
silvateam.comSilvateam | World leader in plant based extracts

seqirus.com Traffic Sources Chart

seqirus.com Alexa Rank History Chart

seqirus.com aleax

seqirus.com Html To Plain Text

Skip to main content Global Selector News Partnering Contact Our Company Our Company Corporate Responsibility Corporate Responsibility Disclosures Leadership Derived from the expression 'securing health for all of us', Seqirus has public health protection at its core. Learn more At Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities. Learn more Expertise Expertise Influenza Influenza Pandemic Response Solutions Antivenom & Q fever Vaccines In-licensing Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and manufacturing plants in the US, UK and Australia. Learn more Seqirus is on the front line of battling influenza, working hard to suppress costly and life-threatening epidemics and pandemics. Vaccination is the most effective way to prevent influenza . Learn more R&D R&D Research Practices Investigator Initiated Studies Our Seqirus research and development group provides support to ensure the conditions are optimised for efficient vaccine manufacture. Activities also focus on improving the effectiveness of current influenza vaccines and their manufacturing processes. Learn more At Seqirus, we are committed to carrying out R&D in an ethical and transparent way as well as in accordance with government regulations and industry codes for good practice. Learn more Manufacturing Manufacturing Global Manufacturing Network Technologies Technical Development Quality & Safety One of the largest influenza vaccine companies in the world, Seqirus operates state-of-the-art manufacturing facilities in three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world. Learn more Seqirus utilises both egg and cell-based production technologies and we offer a broadest portfolio of influenza vaccines. We have commercialised the only adjuvanted seasonal influenza vaccine for older adults and paediatrics and offer two different types of quadrivalent influenza vaccines. Learn more Products Careers Careers See Yourself at Seqirus Discover Our People Diversity and Inclusion How we care for you at Seqirus When you join Seqirus, you join a team dedicated to protecting people and communities from influenza. It's a feeling of purpose and possibility that inspires us every day. Learn more It doesn't matter whether you are a scientist or an administrator, a marketer or an operator - as long as you are inspired by the chance to create something that will help others, you can find your role at Seqirus. Learn more Seqirus Back Our Company Our Company Corporate Responsibility Corporate Responsibility Disclosures Leadership Expertise Expertise Influenza Influenza Pandemic Response Solutions Antivenom & Q fever Vaccines In-licensing R&D R&D Research Practices Investigator Initiated Studies Manufacturing Manufacturing Global Manufacturing Network Technologies Technical Development Quality & Safety Products Careers Careers See Yourself at Seqirus Discover Our People Diversity and Inclusion How we care for you at Seqirus News Partnering Contact COVID-19 Update: Safeguarding our people and communities remains our top priority. Learn More CSL Group collaborates with Global Plasma Leaders to accelerate development of potential COVID-19 Hyperimmune therapy Read more We are a global force in the fight against influenza, on the front line of protection since 1918. Watch our documentary -- Popular search terms: Influenza Vaccines Careers Pandemic Preparedness Expertise COVID-19: A Message from Our CEO "As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited We're committed to the fight against influenza At Seqirus, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza vaccines help protect millions of people. We find solutions to big, complex, challenging problems, and we see the results in the world around us. Then we do it all over again the following year. Seqirus is one of the world’s largest influenza vaccine companies. We were created when our parent company, CSL Limited, acquired the Novartis influenza vaccine business and combined it with vaccine subsidiary, bioCSL. 100 years of securing healthy lives Seqirus has a rich heritage in guarding against influenza. As part of CSL, our experience dates back to the deadly 1918 influenza pandemic and we’ve worked with global health partners on the front line of influenza protection ever since. Learn more Join us on the front line When you join Seqirus, you join a skilled and passionate team dedicated to protecting people and communities from influenza. It's the feeling of purpose and possibility that inspires us every day. Careers This website is intended for people seeking information on Seqirus' worldwide business. Our country sites can be located in our Worldwide Directory . UK/FLU/0519/0080 August 2019 Our Company We are one of the world’s largest influenza vaccine companies with a unique singular focus on influenza. Learn more Products Our broad range of influenza vaccines help safeguard people and communities all around the globe. Learn more Contact There are many ways to contact us and connect to our offices around the world. Learn more Report an Adverse Event Cookie Policy Privacy Statement Modern Slavery Terms of Use Sitemap © 2020 Seqirus. All rights reserved. Seqirus is a trademark of Seqirus UK Limited or its affiliates. Popular search terms: Influenza Vaccines Careers Pandemic Preparedness Expertise Corporate CSL Limited (Global) Seqirus Seqirus (Global) Seqirus (Australia) Seqirus (New Zealand) Seqirus (Germany) Seqirus (Italy) Seqirus (US) Seqirus (Canada) This website uses cookies to ensure the best possible user experience. Please note that if you do not accept the cookies, your user experience may be significantly less positive. You will find more information on how to disable the use of cookies in our Cookie Policy ....

seqirus.com Whois

"domain_name": [ "SEQIRUS.COM", "seqirus.com" ], "registrar": "MarkMonitor, Inc.", "whois_server": "whois.markmonitor.com", "referral_url": null, "updated_date": [ "2020-04-06 09:11:38", "2020-04-06 02:11:38-07:00" ], "creation_date": [ "2015-05-08 13:03:58", "2015-05-08 06:03:58-07:00" ], "expiration_date": [ "2022-05-08 13:03:58", "2022-05-08 00:00:00-07:00" ], "name_servers": [ "NS1.MARKMONITOR.COM", "NS3.MARKMONITOR.COM", "NS5.MARKMONITOR.COM", "ns3.markmonitor.com", "ns5.markmonitor.com", "ns1.markmonitor.com" ], "status": [ "clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited", "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited", "clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)", "clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)", "clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)" ], "emails": [ "abusecomplaints@markmonitor.com", "whoisrequest@markmonitor.com" ], "dnssec": "unsigned", "name": null, "org": "Seqirus UK Limited", "address": null, "city": null, "state": "Berkshire", "zipcode": null, "country": "UK"